Cargando…

Single coronary artery presenting dilated cardiomyopathy and hyperlipidemia with the SCN5A and APOA5 gene mutation: A case report and review of the literature

We present a 55-year-old man with chest tightness and dyspnoea after activity lasting for 2 months who was diagnosed with single coronary artery (SCA) and presented with dilated cardiomyopathy (DCM) with the c.1858C > T mutation in the SCN5A gene. The computed tomography coronary angiogram (CTCA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiaoxia, Kong, Jing, Niu, Tingting, Chen, Liang, Yang, Jingjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242075/ https://www.ncbi.nlm.nih.gov/pubmed/37288251 http://dx.doi.org/10.3389/fcvm.2023.1113886

Ejemplares similares

Case Report: Family Curse: An SCN5A Mutation, c.611C>A, p.A204E Associated With a Family History of Dilated Cardiomyopathy and Arrhythmia
por: Huang, Wen, et al.
Publicado: (2022)

Corrigendum: Case Report: Family Curse: An SCN5A Mutation, c.611C>A, p.A204E Associated With a Family History of Dilated Cardiomyopathy and Arrhythmia
por: Huang, Wen, et al.
Publicado: (2022)

Familial Dilated Cardiomyopathy and Sudden Cardiac Arrest: New Association with a SCN5A Mutation
por: Rico, Yolanda, et al.
Publicado: (2021)

A common polymorphism in the SCN5A gene is associated with dilated cardiomyopathy
por: Mazzaccara, Cristina, et al.
Publicado: (2018)

Novel presentation of SCN5A nonsense mutation as SCN5A overlap syndrome
por: Ahn, Hyo-Jeong, et al.
Publicado: (2021)

Disease Modifiers of Inherited SCN5A Channelopathy
por: Verkerk, Arie O., et al.
Publicado: (2018)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

A combination of quinidine/mexiletine reduces arrhythmia in dilated cardiomyopathy in two patients with R814W SCN5A mutation
por: Zakrzewska‐Koperska, Joanna, et al.
Publicado: (2020)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Compound Heterozygous SCN5A Mutations in Severe Sodium Channelopathy With Brugada Syndrome: A Case Report
por: Nijak, Aleksandra, et al.
Publicado: (2020)

Genotype‐specific pathogenic effects in human dilated cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)

A Case of SCN5A Mutation-Associated Isolated Left Atrial Standstill and Ischemic Stroke
por: Kang, Dong-Seon, et al.
Publicado: (2022)

A multifactorial aetiology for dilated cardiomyopathy
por: Herrera Flores, Cristian, et al.
Publicado: (2021)

Identification of SCN5a p.C335R Variant in a Large Family with Dilated Cardiomyopathy and Conduction Disease
por: Sedaghat-Hamedani, Farbod, et al.
Publicado: (2021)

The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy
por: Kadhi, Ayat, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a(+/−) mouse model
por: Martin, Claire A., et al.
Publicado: (2011)

EGCG Alleviates Obesity-Induced Myocardial Fibrosis in Rats by Enhancing Expression of SCN5A
por: Yi, Haoan, et al.
Publicado: (2022)

FRI104 A Case Of Nephrotic Syndrome Presenting With Hyperlipidemia
por: Romao, Isabela J, et al.
Publicado: (2023)

Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/− hearts
por: Zhang, Y, et al.
Publicado: (2014)

Case report: Right coronary artery to left ventricular fistula complicated with coronary artery dilation presenting as persistent cardiogenic ischemic chest pain
por: Wang, Yuehai, et al.
Publicado: (2023)

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure
por: Liu, Chang, et al.
Publicado: (2021)

Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease
por: Negi, Priyanka, et al.
Publicado: (2022)

Atrial arrhythmogenesis in wild-type and Scn5a+/Δ murine hearts modelling LQT3 syndrome
por: Dautova, Yana, et al.
Publicado: (2009)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022)

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

DILATED CARDIOMYOPATHY WITH CARDIOGENIC SHOCK SECONDARY TO COVID-19 INFECTION
por: RICHARDSON, AUSTIN, et al.
Publicado: (2022)

Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in ΔKPQ Scn5a murine hearts modelling human long QT 3 syndrome
por: Thomas, G, et al.
Publicado: (2008)

Case report: State-of-the-art risk-modifying treatment of sudden cardiac death in an asymptomatic patient with a mutation in the SCN5A gene and a review of the literature
por: Brlek, Petar, et al.
Publicado: (2023)

Case report: A new de novo mutation of the Troponin T2 gene in a Chinese patient with dilated cardiomyopathy
por: Yang, Huan, et al.
Publicado: (2023)

Delayed conduction and its implications in murine Scn5a(+/−) hearts: independent and interacting effects of genotype, age, and sex
por: Jeevaratnam, Kamalan, et al.
Publicado: (2010)

Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome
por: Wu, Yanhua, et al.
Publicado: (2016)

Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers
por: Verdonschot, Job A. J., et al.
Publicado: (2019)

Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia
por: Busnelli, Marco, et al.
Publicado: (2022)

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy
por: Zheng, Youyang, et al.
Publicado: (2022)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Early-stage alcohol-induced cardiomyopathy: not so much dilatation and dysfunction
por: Carrillo-Bailen, Magdalena, et al.
Publicado: (2023)

Development and validation of nomogram for unplanned ICU admission in patients with dilated cardiomyopathy
por: Li, Xiao-Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c39esfijna01u50ea2rmda4ol9